Arch Pharmalabs, 14% 16feb2019, INR (FIGI BBG003BKRYN7, INE182F07105)
国内債券, Secured
国内債券, Secured
|
The company is a pharmaceutical company aligned across two business verticals viz. Products and Services. Their Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and ...
The company is a pharmaceutical company aligned across two business verticals viz. Products and Services. Their Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. The company has evolved the business and has, over the years, extended from manufacturing APIs and Intermediates to add CRAMS to the offerings, which has significant potential for the growth of the business.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡